If given the green light by the FDA, a CAR T cell therapy from Kyverna Therapeutics would be the first approved treatment for stiff person syndrome.
If given the green light by the FDA, a CAR T cell therapy from Kyverna Therapeutics would be the first approved treatment for stiff person syndrome.
AI could turn scientific papers into research assistants 
A lifesaving medication is not behind the drop in U.S. overdose deaths 
Peek into hidden worlds revealed by the 2026 Nikon Small World contest 
What can minerals tell us about Earth’s past? This geologist is finding out 
Rule breaking by just a few people can be contagious 
A quantum computing feat brings the ‘megaquops’ era a step closer 
This ‘living drug’ could change the course of autoimmune disease 
What a Seawater Sample Can Tell Scientists About Ocean Health 
Bangladesh’s Hidden Climate Bill: How Much Are We Losing Without Counting It? 
International Day of Climate Action 2026